Spontaneously hypertensive rats (SHR) are characterized by extreme elevatio
ns of blood pressure. The genetic factors underlying this are yet to be ide
ntified. Here we demonstrate, in vivo, that in SHR and normotensive Wistar-
Kyoto rats (WKY), injection of the mitogen-activated protein kinase inhibit
or PD 098,059 bilaterally into the rostral ventrolateral medulla (RVLM) dra
matically lowers arterial pressure. PD 098,059 does not alter the responses
evoked by microinjection of glutamate into the RVLM or brief apnea. Wortma
nnin (phosphatidylinositol-3 kinase inhibitor) bilaterally into the RVLM ca
uses a 35 +/-4% fall in arterial pressure in SHR but has no effect in WKY.
Furthermore, wortmannin reduces the pressor response evoked by microinjecti
on of angiotensin (Ang) II in the RVLM of SHR compared with WKY. The respon
se to Ang II microinjection into the RVLM of WKY was unaffected by wortmann
in. Simultaneous bilateral injections of PD 098,059 and wortmannin into the
RVLM abolished the response to exogenous Ang II in the RVLM but did not af
fect the response evoked by glutamate in either SHR or WKY. Thus, it appear
s that PD 098,059- and/or wortmannin-sensitive mechanisms are not involved
in the responses evoked by glutamate in the RVLM and that these kinase inhi
bitors are not neurotoxic. We conclude that a PD 098,059-sensitive pathway
in the RVLM of SHR and WKY tonically regulates arterial pressure and that a
wortmannin-sensitive pathway in the RVLM is important in the maintenance o
f hypertension in SHR. This may be related to a phosphatidylinositol-3 kina
se-dependent mechanism involved in the action of Ang II on the Ang II type
I receptor.